Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cell-free DNA as a potential biomarker for preeclampsia.

Literature DB >> 34696685

Cell-free DNA as a potential biomarker for preeclampsia.

Abstract

Entities: Chemical

Keywords: Biomarker; cell-free DNA; hypertension; hypertensive disorders of pregnancy; preeclampsia; pregnancy; therapeutic target

Mesh：

Substances：

Year: 2021 PMID： 34696685 PMCID： PMC8671212 DOI： 10.1080/14737159.2021.1997593

Source DB: PubMed Journal: Expert Rev Mol Diagn ISSN： 1473-7159 Impact factor: 5.225

× No keyword cloud information.

30 in total

1. Exposure to stimulatory CpG oligonucleotides during gestation induces maternal hypertension and excess vasoconstriction in pregnant rats.

Authors: Styliani Goulopoulou; Camilla F Wenceslau; Cameron G McCarthy; Takayuki Matsumoto; R Clinton Webb
Journal: Am J Physiol Heart Circ Physiol Date: 2016-02-12 Impact factor: 4.733

2. Higher mitochondrial DNA content in human IUGR placenta.

Authors: D Lattuada; F Colleoni; A Martinelli; A Garretto; R Magni; T Radaelli; I Cetin
Journal: Placenta Date: 2008-11-12 Impact factor: 3.481

Review 3. Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis.

Authors: Elena Contro; Dalila Bernabini; Antonio Farina
Journal: Mol Diagn Ther Date: 2017-04 Impact factor: 4.074

4. Circulating Nucleic Acids in Maternal Plasma and Serum in Pregnancy Complications: Are They Really Useful in Clinical Practice? A Systematic Review.

Authors: Ilma Floriana Carbone; Alessandro Conforti; Silvia Picarelli; Danila Morano; Carlo Alviggi; Antonio Farina
Journal: Mol Diagn Ther Date: 2020-08 Impact factor: 4.074

5. Maternal plasma cell-free DNA in the prediction of pre-eclampsia.

Authors: D L Rolnik; N O'Gorman; M Fiolna; D van den Boom; K H Nicolaides; L C Poon
Journal: Ultrasound Obstet Gynecol Date: 2014-12-04 Impact factor: 7.299

6. Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia.

Authors: Francesca Salvianti; Annalisa Inversetti; Maddalena Smid; Luca Valsecchi; Massimo Candiani; Mario Pazzagli; Laura Cremonesi; Maurizio Ferrari; Pamela Pinzani; Silvia Galbiati
Journal: Placenta Date: 2015-07-07 Impact factor: 3.481

7. Circulating fetal and total cell-free DNA, and sHLA-G in black South African women with gestational hypertension and pre-eclampsia.

Authors: Simeon Eche; Irene Mackraj; Jagidesa Moodley
Journal: Hypertens Pregnancy Date: 2017-11-08 Impact factor: 2.108

8. Mitochondrial DNA Copy Number in Peripheral Blood in the First Trimester of Pregnancy and Different Preeclampsia Clinical Phenotypes Development: A Pilot Study.

Authors: Andrea Busnelli; Debora Lattuada; Stefania Ferrari; Marco Reschini; Barbara Colciaghi; Edgardo Somigliana; Luigi Fedele; Enrico Ferrazzi
Journal: Reprod Sci Date: 2018-10-08 Impact factor: 3.060

9. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction.

Authors: А О Karapetian; О R Baev; А А Sadekova; А М Krasnyi; G T Sukhikh
Journal: Reprod Sci Date: 2021-01-21 Impact factor: 3.060

10. Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation.

Authors: Tal Rafaeli-Yehudai; Majdi Imterat; Amos Douvdevani; Dan Tirosh; Neta Benshalom-Tirosh; Salvatore Andrea Mastrolia; Ruthy Beer-Weisel; Vered Klaitman; Reut Riff; Shirley Greenbaum; Alex Alioshin; Gal Rodavsky Hanegbi; Giuseppe Loverro; Mariana Rita Catalano; Offer Erez
Journal: PLoS One Date: 2018-07-12 Impact factor: 3.240

1 in total

1. Association of fetal fraction with hypertensive disorders of pregnancy incidence and disease severity.

Authors: Raj Shree; Teodora R Kolarova; Hayley J MacKinnon; Christina M Lockwood; Suchitra Chandrasekaran
Journal: Am J Obstet Gynecol MFM Date: 2022-05-27

1 in total